Givaudan Forecast, price target & analysts
Givaudan Target price 2025 - Analyst rating & recommendation
Givaudan Classifications & Recommendation:
Givaudan Price Target
| Target Price | CHF4,228.71 |
| Price | CHF3,802.00 |
| Potential | 11.22% |
| Number of Estimates | 21 |
| 21 Analysts have issued a price target Givaudan 2026 . The average Givaudan target price is CHF4,228.71. This is 11.22% higher than the current stock price. The highest price target is CHF5,100.00 34.14% , the lowest is CHF3,400.00 10.57% . | |
| A rating was issued by 23 analysts: 8 Analysts recommend Givaudan to buy, 10 to hold and 5 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Givaudan stock has an average upside potential 2026 of 11.22% . Most analysts recommend the Givaudan stock at Hold. |
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion CHF | 7.41 | 7.80 |
| 7.19% | 5.29% | |
| EBITDA Margin | 23.87% | 24.16% |
| 12.12% | 1.23% | |
| Net Margin | 14.72% | 14.85% |
| 13.88% | 0.91% |
20 Analysts have issued a sales forecast Givaudan 2025 . The average Givaudan sales estimate is CHF7.8b . This is 5.29% higher than the revenue of the last 12 months(TTM). The highest sales forecast is CHF8.0b 7.39% , the lowest is CHF7.7b 3.64% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | CHF7.4b | 7.19% |
|---|---|---|
| 2025 | CHF7.8b | 5.29% |
| 2026 | CHF8.2b | 4.91% |
| 2027 | CHF8.6b | 5.13% |
| 2028 | CHF9.1b | 5.53% |
| 2029 | CHF9.7b | 6.92% |
20 Analysts have issued an Givaudan EBITDA forecast 2025. The average Givaudan EBITDA estimate is CHF1.9b . This is 6.58% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is CHF1.9b 9.50% , the lowest is CHF1.7b 5.91% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | CHF1.8b | 20.18% |
|---|---|---|
| 2025 | CHF1.9b | 6.58% |
| 2026 | CHF2.0b | 5.03% |
| 2027 | CHF2.1b | 5.37% |
| 2028 | CHF2.1b | 2.92% |
| 2029 | CHF2.2b | 1.44% |
EBITDA Margin
| 2024 | 23.87% | 12.12% |
|---|---|---|
| 2025 | 24.16% | 1.23% |
| 2026 | 24.19% | 0.12% |
| 2027 | 24.24% | 0.21% |
| 2028 | 23.64% | 2.48% |
| 2029 | 22.43% | 5.12% |
14 Givaudan Analysts have issued a net profit forecast 2025. The average Givaudan net profit estimate is CHF1.2b . This is 6.29% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is CHF1.2b 9.74% , the lowest is CHF1.1b 1.82% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | CHF1.1b | 22.06% |
|---|---|---|
| 2025 | CHF1.2b | 6.29% |
| 2026 | CHF1.3b | 8.57% |
| 2027 | CHF1.4b | 7.58% |
| 2028 | CHF1.4b | 1.46% |
| 2029 | CHF1.4b | 1.35% |
Net Margin
| 2024 | 14.72% | 13.88% |
|---|---|---|
| 2025 | 14.85% | 0.91% |
| 2026 | 15.37% | 3.50% |
| 2027 | 15.73% | 2.34% |
| 2028 | 15.13% | 3.81% |
| 2029 | 14.34% | 5.22% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share CHF | 118.17 | 125.60 |
| 22.06% | 6.29% | |
| P/E | 30.27 | |
| EV/Sales | 5.01 |
14 Analysts have issued a Givaudan forecast for earnings per share. The average Givaudan EPS is CHF125.60 . This is 6.29% higher than earnings per share in the financial year 2024. The highest EPS forecast is CHF129.68 9.74% , the lowest is CHF116.02 1.82% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | CHF118.17 | 22.06% |
|---|---|---|
| 2025 | CHF125.60 | 6.29% |
| 2026 | CHF136.37 | 8.57% |
| 2027 | CHF146.71 | 7.58% |
| 2028 | CHF148.85 | 1.46% |
| 2029 | CHF150.87 | 1.36% |
P/E ratio
| Current | 32.17 | 24.13% |
|---|---|---|
| 2025 | 30.27 | 5.91% |
| 2026 | 27.88 | 7.90% |
| 2027 | 25.92 | 7.03% |
| 2028 | 25.54 | 1.47% |
| 2029 | 25.20 | 1.33% |
Based on analysts' sales estimates for 2025, the Givaudan stock is valued at an EV/Sales of 5.01 and an P/S ratio of 4.49 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 5.27 | 13.61% |
|---|---|---|
| 2025 | 5.01 | 5.01% |
| 2026 | 4.77 | 4.68% |
| 2027 | 4.54 | 4.88% |
| 2028 | 4.30 | 5.24% |
| 2029 | 4.02 | 6.47% |
P/S ratio
| Current | 4.73 | 13.60% |
|---|---|---|
| 2025 | 4.49 | 5.02% |
| 2026 | 4.28 | 4.68% |
| 2027 | 4.08 | 4.88% |
| 2028 | 3.86 | 5.24% |
| 2029 | 3.61 | 6.47% |
Current Givaudan Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| RESEARCH PARTNERS AG |
Hold
➜
Buy
|
Upgrade | Jan 06 2025 |
| BNP PARIBAS EXANE |
Neutral
➜
Neutral
|
Unchanged | Jan 05 2025 |
| BAADER HELVEA EQUITY RESEARCH |
Buy
➜
Buy
|
Unchanged | Dec 16 2024 |
| BERENBERG |
Hold
➜
Hold
|
Unchanged | Dec 08 2024 |
| STIFEL EUROPE |
Hold
➜
Hold
|
Unchanged | Nov 07 2024 |
| DZ BANK |
Hold
➜
Hold
|
Unchanged | Oct 16 2024 |
| REDBURN ATLANTIC |
Neutral
➜
Neutral
|
Unchanged | Oct 10 2024 |
| Analyst Rating | Date |
|---|---|
|
Upgrade
RESEARCH PARTNERS AG:
Hold
➜
Buy
|
Jan 06 2025 |
|
Unchanged
BNP PARIBAS EXANE:
Neutral
➜
Neutral
|
Jan 05 2025 |
|
Unchanged
BAADER HELVEA EQUITY RESEARCH:
Buy
➜
Buy
|
Dec 16 2024 |
|
Unchanged
BERENBERG:
Hold
➜
Hold
|
Dec 08 2024 |
|
Unchanged
STIFEL EUROPE:
Hold
➜
Hold
|
Nov 07 2024 |
|
Unchanged
DZ BANK:
Hold
➜
Hold
|
Oct 16 2024 |
|
Unchanged
REDBURN ATLANTIC:
Neutral
➜
Neutral
|
Oct 10 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
